2-Azetidinone – A new profile of various pharmacological activities
2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of ce...
Gespeichert in:
Veröffentlicht in: | European journal of medicinal chemistry 2010-12, Vol.45 (12), p.5541-5560 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 5560 |
---|---|
container_issue | 12 |
container_start_page | 5541 |
container_title | European journal of medicinal chemistry |
container_volume | 45 |
creator | Mehta, Parul D. Sengar, N.P.S. Pathak, A.K. |
description | 2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of cephalosporinase and ezetimibe as a cholesterol absorption inhibitor proved potential of 2-azetidinone moiety. Subsequently 2-azetidinones were highlighted as a potent mechanism based inhibitor of several enzymes like human tryptase, chymase, thrombin, leukocyte elastase, human cytomegalovirus protease and serine protease enzyme. These derivatives also known to possess antitubercular, anti-inflammatory, antitumor, anti-HIV, antiparkinsonian, antidiabetic and vasopressin V1a antagonist activity. The present review article focuses on the pharmacological profile of 2-azetidinones with their potential activities.
2-Azetidinone and their derivatives occupy a central place in medicinal chemistry due to their diverse and broad pharmacological profile. This article focuses on the various pharmacological profile of 2-azetidinone scaffold and development of novel derivatives with their potential activity.
[Display omitted] |
doi_str_mv | 10.1016/j.ejmech.2010.09.035 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_812134349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523410006835</els_id><sourcerecordid>812134349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-bfc8100c1ecd56735f2334f229a307ad5256ce05269eda63f0d13e2eb93e15593</originalsourceid><addsrcrecordid>eNp9kMtKA0EQRRtRTHz8gchsxNXE6tdMZiOEEB8QcKPrptNTbTrMI3ZPIrryH_xDv8QOibpzVVCcW3U5hJxRGFCg2dVigIsazXzAIK6gGACXe6RP82yYcibFPukDYzyVjIseOQphAQAyAzgkPQZFDsNC9smEpaN37FzpmrbB5OvjMxklDb4mS99aV2HS2mStvWtXIVnOta-1aav22RldJdp0bu06h-GEHFhdBTzdzWPydDN5HN-l04fb-_Fomhoh8y6dWTOkAIaiKWWWc2kZ58IyVmgOuS4lk5lBkCwrsNQZt1BSjgxnBUcqZcGPyeX2bmz3ssLQqdoFg1WlG4wN1ZAyygUXG1JsSePbEDxatfSu1v5NUVAbf2qhtv7Uxp-CQkV_MXa-e7Ca1Vj-hn6EReBiB-gQHVivG-PCH8dFLqigkbvechh1rB16FYzDxmDpPJpOla37v8k30UqPtQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>812134349</pqid></control><display><type>article</type><title>2-Azetidinone – A new profile of various pharmacological activities</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Mehta, Parul D. ; Sengar, N.P.S. ; Pathak, A.K.</creator><creatorcontrib>Mehta, Parul D. ; Sengar, N.P.S. ; Pathak, A.K.</creatorcontrib><description>2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of cephalosporinase and ezetimibe as a cholesterol absorption inhibitor proved potential of 2-azetidinone moiety. Subsequently 2-azetidinones were highlighted as a potent mechanism based inhibitor of several enzymes like human tryptase, chymase, thrombin, leukocyte elastase, human cytomegalovirus protease and serine protease enzyme. These derivatives also known to possess antitubercular, anti-inflammatory, antitumor, anti-HIV, antiparkinsonian, antidiabetic and vasopressin V1a antagonist activity. The present review article focuses on the pharmacological profile of 2-azetidinones with their potential activities.
2-Azetidinone and their derivatives occupy a central place in medicinal chemistry due to their diverse and broad pharmacological profile. This article focuses on the various pharmacological profile of 2-azetidinone scaffold and development of novel derivatives with their potential activity.
[Display omitted]</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2010.09.035</identifier><identifier>PMID: 20970895</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Kidlington: Elsevier Masson SAS</publisher><subject>2-Azetidinone ; Animals ; Anti-Infective Agents - chemistry ; Anti-Infective Agents - pharmacology ; Antifungal Agents - chemistry ; Antifungal Agents - pharmacology ; Antiparkinson Agents - chemistry ; Antiparkinson Agents - pharmacology ; Azetidines - chemistry ; Azetidines - pharmacology ; Biological activity ; Biological and medical sciences ; Four membered heterocyclic ring ; Humans ; Hypoglycemic Agents - chemistry ; Hypoglycemic Agents - pharmacology ; Medical sciences ; Miscellaneous ; Pharmacology. Drug treatments ; β-Lactam</subject><ispartof>European journal of medicinal chemistry, 2010-12, Vol.45 (12), p.5541-5560</ispartof><rights>2010 Elsevier Masson SAS</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-bfc8100c1ecd56735f2334f229a307ad5256ce05269eda63f0d13e2eb93e15593</citedby><cites>FETCH-LOGICAL-c457t-bfc8100c1ecd56735f2334f229a307ad5256ce05269eda63f0d13e2eb93e15593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2010.09.035$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23474141$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20970895$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mehta, Parul D.</creatorcontrib><creatorcontrib>Sengar, N.P.S.</creatorcontrib><creatorcontrib>Pathak, A.K.</creatorcontrib><title>2-Azetidinone – A new profile of various pharmacological activities</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of cephalosporinase and ezetimibe as a cholesterol absorption inhibitor proved potential of 2-azetidinone moiety. Subsequently 2-azetidinones were highlighted as a potent mechanism based inhibitor of several enzymes like human tryptase, chymase, thrombin, leukocyte elastase, human cytomegalovirus protease and serine protease enzyme. These derivatives also known to possess antitubercular, anti-inflammatory, antitumor, anti-HIV, antiparkinsonian, antidiabetic and vasopressin V1a antagonist activity. The present review article focuses on the pharmacological profile of 2-azetidinones with their potential activities.
2-Azetidinone and their derivatives occupy a central place in medicinal chemistry due to their diverse and broad pharmacological profile. This article focuses on the various pharmacological profile of 2-azetidinone scaffold and development of novel derivatives with their potential activity.
[Display omitted]</description><subject>2-Azetidinone</subject><subject>Animals</subject><subject>Anti-Infective Agents - chemistry</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Antifungal Agents - chemistry</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antiparkinson Agents - chemistry</subject><subject>Antiparkinson Agents - pharmacology</subject><subject>Azetidines - chemistry</subject><subject>Azetidines - pharmacology</subject><subject>Biological activity</subject><subject>Biological and medical sciences</subject><subject>Four membered heterocyclic ring</subject><subject>Humans</subject><subject>Hypoglycemic Agents - chemistry</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pharmacology. Drug treatments</subject><subject>β-Lactam</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKA0EQRRtRTHz8gchsxNXE6tdMZiOEEB8QcKPrptNTbTrMI3ZPIrryH_xDv8QOibpzVVCcW3U5hJxRGFCg2dVigIsazXzAIK6gGACXe6RP82yYcibFPukDYzyVjIseOQphAQAyAzgkPQZFDsNC9smEpaN37FzpmrbB5OvjMxklDb4mS99aV2HS2mStvWtXIVnOta-1aav22RldJdp0bu06h-GEHFhdBTzdzWPydDN5HN-l04fb-_Fomhoh8y6dWTOkAIaiKWWWc2kZ58IyVmgOuS4lk5lBkCwrsNQZt1BSjgxnBUcqZcGPyeX2bmz3ssLQqdoFg1WlG4wN1ZAyygUXG1JsSePbEDxatfSu1v5NUVAbf2qhtv7Uxp-CQkV_MXa-e7Ca1Vj-hn6EReBiB-gQHVivG-PCH8dFLqigkbvechh1rB16FYzDxmDpPJpOla37v8k30UqPtQ</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Mehta, Parul D.</creator><creator>Sengar, N.P.S.</creator><creator>Pathak, A.K.</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>2-Azetidinone – A new profile of various pharmacological activities</title><author>Mehta, Parul D. ; Sengar, N.P.S. ; Pathak, A.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-bfc8100c1ecd56735f2334f229a307ad5256ce05269eda63f0d13e2eb93e15593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>2-Azetidinone</topic><topic>Animals</topic><topic>Anti-Infective Agents - chemistry</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Antifungal Agents - chemistry</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antiparkinson Agents - chemistry</topic><topic>Antiparkinson Agents - pharmacology</topic><topic>Azetidines - chemistry</topic><topic>Azetidines - pharmacology</topic><topic>Biological activity</topic><topic>Biological and medical sciences</topic><topic>Four membered heterocyclic ring</topic><topic>Humans</topic><topic>Hypoglycemic Agents - chemistry</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pharmacology. Drug treatments</topic><topic>β-Lactam</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mehta, Parul D.</creatorcontrib><creatorcontrib>Sengar, N.P.S.</creatorcontrib><creatorcontrib>Pathak, A.K.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mehta, Parul D.</au><au>Sengar, N.P.S.</au><au>Pathak, A.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>2-Azetidinone – A new profile of various pharmacological activities</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>45</volume><issue>12</issue><spage>5541</spage><epage>5560</epage><pages>5541-5560</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of cephalosporinase and ezetimibe as a cholesterol absorption inhibitor proved potential of 2-azetidinone moiety. Subsequently 2-azetidinones were highlighted as a potent mechanism based inhibitor of several enzymes like human tryptase, chymase, thrombin, leukocyte elastase, human cytomegalovirus protease and serine protease enzyme. These derivatives also known to possess antitubercular, anti-inflammatory, antitumor, anti-HIV, antiparkinsonian, antidiabetic and vasopressin V1a antagonist activity. The present review article focuses on the pharmacological profile of 2-azetidinones with their potential activities.
2-Azetidinone and their derivatives occupy a central place in medicinal chemistry due to their diverse and broad pharmacological profile. This article focuses on the various pharmacological profile of 2-azetidinone scaffold and development of novel derivatives with their potential activity.
[Display omitted]</abstract><cop>Kidlington</cop><pub>Elsevier Masson SAS</pub><pmid>20970895</pmid><doi>10.1016/j.ejmech.2010.09.035</doi><tpages>20</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0223-5234 |
ispartof | European journal of medicinal chemistry, 2010-12, Vol.45 (12), p.5541-5560 |
issn | 0223-5234 1768-3254 |
language | eng |
recordid | cdi_proquest_miscellaneous_812134349 |
source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
subjects | 2-Azetidinone Animals Anti-Infective Agents - chemistry Anti-Infective Agents - pharmacology Antifungal Agents - chemistry Antifungal Agents - pharmacology Antiparkinson Agents - chemistry Antiparkinson Agents - pharmacology Azetidines - chemistry Azetidines - pharmacology Biological activity Biological and medical sciences Four membered heterocyclic ring Humans Hypoglycemic Agents - chemistry Hypoglycemic Agents - pharmacology Medical sciences Miscellaneous Pharmacology. Drug treatments β-Lactam |
title | 2-Azetidinone – A new profile of various pharmacological activities |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A40%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=2-Azetidinone%20%E2%80%93%20A%20new%20profile%20of%20various%20pharmacological%20activities&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Mehta,%20Parul%20D.&rft.date=2010-12-01&rft.volume=45&rft.issue=12&rft.spage=5541&rft.epage=5560&rft.pages=5541-5560&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2010.09.035&rft_dat=%3Cproquest_cross%3E812134349%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=812134349&rft_id=info:pmid/20970895&rft_els_id=S0223523410006835&rfr_iscdi=true |